Pages that link to "Q30994095"

The following pages link to Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells (Q30994095):

Displaying 36 items.

• PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL) (Q26782633) (← links)
• Immunological aspects in chronic lymphocytic leukemia (CLL) development (Q26868630) (← links)
• B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells (Q28245018) (← links)
• Bruton's tyrosine kinase (BTK) inhibitors in clinical trials (Q34039406) (← links)
• Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL. (Q35153215) (← links)
• Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8. (Q35692395) (← links)
• The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia (Q36261329) (← links)
• Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL (Q36404778) (← links)
• Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles (Q36484147) (← links)
• Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications (Q36862781) (← links)
• Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade (Q36867755) (← links)
• Lymphatics: At the Interface of Immunity, Tolerance, and Tumor Metastasis (Q37875904) (← links)
• Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia (Q37967256) (← links)
• Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765). (Q38083077) (← links)
• B cell receptor signaling in chronic lymphocytic leukemia (Q38127513) (← links)
• Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment (Q38550810) (← links)
• B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia (Q38966197) (← links)
• Modeling the chronic lymphocytic leukemia microenvironment in vitro (Q38984569) (← links)
• Molecular characterization of neoplastic and normal "sister" lymphoblastoid B-cell lines from chronic lymphocytic leukemia (Q39214500) (← links)
• Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy (Q39225258) (← links)
• Anti-tumor activity of a B-cell receptor-targeted peptide in a novel disseminated lymphoma xenograft model. (Q39467111) (← links)
• Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia (Q41012392) (← links)
• Bruton's tyrosine kinase: from X-linked agammaglobulinemia toward targeted therapy for B-cell malignancies (Q41524241) (← links)
• A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi. (Q42094298) (← links)
• Immunoglobulin gene repertoire in chronic lymphocytic leukemia: insight into antigen selection and microenvironmental interactions (Q42323395) (← links)
• The role of B cell antigen receptors in mantle cell lymphoma. (Q42682371) (← links)
• Signal-dependent and signal-independent functions of the B-cell receptor in chronic lymphocytic leukemia (Q42922533) (← links)
• B-cell receptor signaling in chronic lymphocytic leukemia leans on Lyn. (Q44022467) (← links)
• Targeting B cell receptor signalling in cancer: preclinical and clinical advances (Q49951221) (← links)
• CD84 mediates CLL-microenvironment interactions (Q51620105) (← links)
• Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis. (Q52643368) (← links)
• Serum levels of soluble calreticulin predict for time to first treatment in early chronic lymphocytic leukaemia. (Q53225340) (← links)
• The times they are a-changin': prognostic markers in the new era of BCR-targeting therapies for CLL. (Q54539817) (← links)
• The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia (Q90569013) (← links)
• Targeting B-cell receptor signaling in leukemia and lymphoma: how and why? (Q92158076) (← links)
• Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles (Q99711995) (← links)